FLC
GRCL

Fifth Lane Capital’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Fifth Lane Capital’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-58,336
Closed -$586K – 172
2023
Q4 		$586K Buy
+58,336
New +$586K 0.69% 15